Matthew Robson
0000-0002-3277-3062
44 papers found
Refreshing results…
Contributions of Inflammatory Cytokine Signaling to the Enduring Effects of Early-Life stress: A Serotonin Connection?
Sigma (σ) Receptors as Potential Therapeutic Targets to Mitigate Psychostimulant Effects
Antagonism of p38 alpha MAPK Signaling Corrects Receptor Hypersensitivity and Altered Social Behavior in the SERT Ala56 Genetic Mouse Model of Autism Spectrum Disorder
Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro
Modeling Clinically Relevant Blast Parameters based on Scaling Principles Produces Functional & Histological Deficits in Rats.
SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation
SN79, a sigma receptor ligand, mitigates methamphetamine‐induced astrocyte and microglial activation
Attenuation of methamphetamine‐induced neurotoxicity by selective sigma receptor ligands: in vivo and in vitro studies
Repetitive Traumatic Brain Injury and Development of Chronic Traumatic Encephalopathy: A Potential Role for Biomarkers in Diagnosis, Prognosis, and Treatment?
sigma Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation
Conditional Elimination of the Interleukin-1 Receptor for the Study of the Impact of Inflammatory Cytokines on Brain and Behavior
Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo
Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus
Sigma receptor ligands attenuate methamphetamine‐induced hyperthermia but do not modulate IL‐1B mRNA expression in select brain regions
Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
Sigma-1 Receptors: Potential Targets for the Treatment of Substance Abuse
CM156, a Sigma Receptor Ligand, Reverses Cocaine-Induced Place Conditioning and Transcriptional Responses in the Brain
Synthesis and Pharmacological Characterization of a Novel Sigma Receptor Ligand with Improved Metabolic Stability and Antagonistic Effects Against Methamphetamine
AC927, a σ Receptor Ligand, Blocks Methamphetamine-Induced Release of Dopamine and Generation of Reactive Oxygen Species in NG108-15 Cells
Synthesis and pharmacological evaluation of indole-based sigma receptor ligands
Missing publications? Search for publications with a matching author name.